(19)
(11)
EP 1 315 830 A2
(12)
(88)
Date of publication A3:
29.08.2002
(43)
Date of publication:
04.06.2003
Bulletin 2003/23
(21)
Application number:
01970681.1
(22)
Date of filing:
07.09.2001
(51)
International Patent Classification (IPC)
7
:
C12Q
1/02
,
C12Q
1/24
,
C12Q
1/70
,
C12P
21/00
,
C12N
5/00
,
C12N
5/08
,
C12N
7/02
,
C12N
15/07
,
C12N
15/09
,
A61K
49/00
,
A61K
49/14
,
A61K
38/03
,
A61K
38/08
(86)
International application number:
PCT/US0128/044
(87)
International publication number:
WO 0202/0723
(
14.03.2002
Gazette 2002/11)
(84)
Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI
(30)
Priority:
08.09.2000
US 231266 P
17.01.2001
US 765101
(71)
Applicant:
BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM
Austin, Texas 78701 (US)
(72)
Inventors:
ARAP, Wadih
Houston, TX 77025 (US)
PASQUALINI, Renata
Houston, tX 77025 (US)
(74)
Representative:
Becker Kurig Straus
PatentanwälteBavariastrasse 7
80336 München
80336 München (DE)
(54)
COMPOSITIONS AND METHODS FOR TARGETING PEPTIDES IN HUMANS IN VIVO